Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
This study is currently recruiting participants.
Verified May 2013 by Dana-Farber Cancer Institute
Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Children's Hospital Boston
University of California, San Francisco
Ann & Robert H Lurie Children's Hospital of Chicago
Children's Healthcare of Atlanta
Children's Hospital Colorado
Children's Hospital Los Angeles
Children's Hospital of Michigan
Children's Hospitals and Clinics of Minnesota
Cook Children's Medical Center
Doernbecher Children's Hospital
Duke University
Johns Hopkins University
Memorial Sloan-Kettering Cancer Center
Miami Children's Hospital
New York University
Penn State Hershey Medical Center
Seattle Children's
University of Louisville
University of Mississippi Medical Center
UT Southwestern Medical Center
Washington University Medical Center
Information provided by (Responsible Party):
Mark W. Kieran, MD, PhD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01182350
First received: August 12, 2010
Last updated: May 18, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |